Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient.

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing’s disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global endocrine testing market report, along with forecasts for growth at the global, regional and country-level from 2021-2026. Our report has categorized the market based on region, test type, technology and end use.

Breakup by Test Type:

  • Thyroid Test
  • Insulin Test
  • Human Chorionic Gonadotropin Test
  • Prolactin Test
  • Luteinizing Hormone Test
  • Progesterone Test
  • Others
     

Breakup by Technology:

  • Immunoassay
  • Tandem Mass Spectroscopy
  • Sensor Technology
  • LC-MS
  • Others
     

Breakup by End Use:

  • Hospitals
  • Ambulatory Care Centers
  • Clinical Laboratories
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Test Type, Technology, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global endocrine testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global endocrine testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global endocrine testing market and who are the key players?
  • What is the degree of competition in the industry?

1   Preface
2   Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Endocrine Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Test Type
    6.1    Thyroid Test
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Insulin Test
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Human Chorionic Gonadotropin Test
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Prolactin Test
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Luteinizing Hormone Test
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Progesterone Test
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Others
        6.7.1 Market Trends
        6.7.2 Market Forecast
7   Market Breakup by Technology
    7.1    Immunoassay
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Tandem Mass Spectroscopy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Sensor Technology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    LC-MS
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8   Market Breakup by End Use
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ambulatory Care Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Clinical Laboratories
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio 
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Agilent Technologies Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials 
           14.3.2.4 SWOT Analysis
        14.3.3    Bio-Rad Laboratories Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio 
           14.3.3.3 Financials 
           14.3.3.4 SWOT Analysis
        14.3.4    BioMerieux SA
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio 
           14.3.4.3 Financials 
           14.3.4.4 SWOT Analysis
        14.3.5    DiaSorin S.p.A.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio 
           14.3.5.3 Financials 
           14.3.5.4 SWOT Analysis
        14.3.6    F. Hoffmann-La Roche AG (Roche Holding AG)
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio 
           14.3.6.3 SWOT Analysis
        14.3.7    Laboratory Corporation of America Holdings
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials 
           14.3.7.4 SWOT Analysis
        14.3.8    Quest Diagnostics Incorporated
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio 
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Siemens Healthineers AG (Siemens Aktiengesellschaft)
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Thermo Fisher Scientific Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio 
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2020
Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2020
Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2020
Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2020
Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11 Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: North America: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: United States: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: China: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: India: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Others: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: France: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Others: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
Figure 90: Global: Endocrine Testing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million US$), 2021-2026
Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Endocrine Testing Market Structure
Table 7: Global: Endocrine Testing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links